Bone Marrow Cancer Discovery Could Help To Identify Drug Targets - Technology Networks

Researchers have discovered that patients with an uncommon type of bone marrow cancer called <i>ASXL1</i>-mutant chronic myelomonocytic leukemia have distinctive epigenetic changes that can activate specific genes and cause the cancer to grow more rapidly.

New research from Mayo Clinic's Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia  an uncommon type of cancer of the bone marrow have distinctiv… [+3595 chars]

full article...